InSightec

Works in Dermatology · Genetic & rare · GI & liver · Metabolic & endocrine · Neurology · Oncology · Psychiatry · Renal & urogenital · Respiratory

InSightec is a clinical trial sponsor. It has 21 active clinical trials with 1,563 planned participants, across 9 therapeutic areas. Since 2021 it has completed 28 trials and stopped 6 early.

Trial track record · since 2021

21Active trials1,563 planned participants
28Completed8 with results posted
6Stopped early18% of finished trials

Pipeline · 21 active trials

StageTrialStatus

Questions about InSightec

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-06.

Approve Suite is not affiliated with InSightec.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.